Zobrazeno 1 - 8
of 8
pro vyhledávání: '"G E Mandoli"'
Autor:
L. Martini, G. E. Mandoli, M. C. Pastore, A. Pagliaro, S. Bernazzali, M. Maccherini, M. Henein, M. Cameli
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Advanced heart failure (AdvHF) can only be treated definitively by heart transplantation (HTx), yet problems such right ventricle dysfunction (RVD), rejection, cardiac allograft vasculopathy (CAV), and primary graft dysfunction (PGD) are linked to a
Externí odkaz:
https://doaj.org/article/9a77cf4a70ba4ba78e379a92886d5435
Autor:
G L Ragazzoni, L Cavigli, L Quer, N Cangiano, A Santoro, G E Mandoli, M C Pastore, M Focardi, M Cameli, S Valente, F D'ascenzi
Publikováno v:
European Journal of Preventive Cardiology. 30
Funding Acknowledgements Type of funding sources: None. Background Training-induced cardiac remodelling is usually accompanied by a harmonic and symmetric adaptation of cardiac chambers. Mild aortic enlargement may be a consequence of intense trainin
Autor:
F Landra, G E Mandoli, C Sciaccaluga, G Gallone, A Pica, L Cavigli, F D'Ascenzi, M Focardi, M Maccherini, S Bernazzali, S Valente, M Cameli
Publikováno v:
European Heart Journal. 43
Background Mechanical circulatory support (MCS) systems are increasingly employed in critical hemodynamic states, such as in cardiogenic shock and end-stage heart failure. A thorough understanding of the complex interactions occurring between heart,
Autor:
G E Mandoli, M Barilli, D Soviero, N Ghionzoli, M Maccherini, S Bernazzali, B Natali, L Cavigli, F D'Ascenzi, M Focardi, M C Pastore, S Valente, M Cameli
Publikováno v:
European Heart Journal. 43
Purpose Amelioration of therapies and increased survival in heart failure (HF) is leading to a growing number of patients affected by advanced HF, with an overall 1-year prognosis ranging from 25 to 75%. The gold standard treatment for end stage HF i
Autor:
G De Carli, G E Mandoli, C Sciaccaluga, G Biagioni, C Marallo, F Turchini, N Ghionzoli, A Melani, M Barilli, M C Pastore, A Gozzetti, E Giacomin, M Focardi, S Valente, M Cameli
Publikováno v:
European Heart Journal. 43
Introduction Cardiac involvement is described as the most important prognostic factor in light chain amyloidosis. An early diagnosis is mandatory to customize the follow-up timing and the best treatment. The aim of the study was to identify the role
Autor:
G E Mandoli, F Landra, A Pica, F Marrese, G Gallone, C Sciaccaluga, L Cavigli, F D'Ascenzi, M Focardi, M Maccherini, S Bernazzali, S Valente, M Cameli
Publikováno v:
European Heart Journal. 43
Background Right ventricular failure (RVF) complicates 10 to 40% of left ventricular assist device (LVAD) implants, with necessity of high dose inotropic/vasodilatory drugs and right ventricular assist devices in severe cases. Prevention of RVF start
Autor:
M C Pastore, G E Mandoli, N Ghionzoli, A Stefanini, F D'Ascenzi, M Lisi, L Cavigli, C Carrucola, M Focardi, S Mondillo, G Patti, S Valente, M Cameli
Publikováno v:
European Heart Journal. 43
Background In acute and chronic heart failure (HF), the relief of congestion is one of the pivotal elements to improve patient's quality of life and prognosis. N-terminal pro-brain natriuretic peptide (NT-proBNP) is a well-known marker of cardiovascu
Autor:
N Ghionzoli, G E Mandoli, A Gismondi, A Di Florio, L Cavigli, C Sciaccaluga, M C Pastore, F D'Ascenzi, M Cameli, M Focardi
Publikováno v:
European Heart Journal. 42
Background Cardiac Magnetic Resonance (CMR) has an important role in subjects presenting with acute myocarditis and preserved ejection fraction (pEF); it is widely used as a non-invasive imaging test in patients with suspected myocarditis, both for d